| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |